Lily Kim, PhD

Lily Kim is a General Partner and Chief Scientific Officer at Awaken Capital and has contributed to the technology commercialization ecosystem for over two decades.

Lily has advised some of the world’s leading biotech and pharmaceutical companies, helped research groups at the Wyss Institute at Harvard commercialize their work, established a community forum for microfluidics commercialization in New England, served on the board of directors of the Hertz Foundation, helped neurotechnology company Kernel get its start, and advised multiple funders and investors.

Lily has an SB in electrical engineering from MIT and a PhD in biomedical engineering at MIT/Harvard.